Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Gynecologic Oncology
|
May 11, 2010
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts
Sara Previdi, Anastasia Malek, Veronica Albertini, et al.
Frontiers in Oncology
|
May 31, 2019
Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
Gianluca Civenni, Domenico Albino, Dheeraj Shinde, et al.
Neoplasia (New York, N.Y.)
|
October 13, 2006
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells
Sara Vignati, Veronica Albertini, Andrea Rinaldi, et al.
Nucleic Acids Research
|
May 4, 2004
DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene
Giuseppina M Carbone, Eileen McGuffie, Sara Napoli, et al.
Plos One
|
May 19, 2010
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer
Paolo Kunderfranco, Maurizia Mello-Grand, Romina Cangemi, et al.
Cancers
|
August 12, 2023
Potential of miRNAs in Plasma Extracellular Vesicle for the Stratification of Prostate Cancer in a South African Population
Dada Oluwaseyi Temilola, Martha Wium, Juliano Paccez, et al.
Cancers
|
December 10, 2021
Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma
Shusil K Pandit, Giada Sandrini, Jessica Merulla, et al.
Cancer Research
|
September 26, 2013
RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer
Gianluca Civenni, Anastasia Malek, Domenico Albino, et al.
Molecular Cancer Therapeutics
|
January 31, 2016
EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB
Gianluca Civenni, Nicole Longoni, Paula Costales, et al.
European Urology
|
July 2, 2011
Epigenetics in prostate cancer: biologic and clinical relevance
Carmen Jerónimo, Patrick J Bastian, Anders Bjartell, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Gynecologic Oncology
|
May 11, 2010
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts
Sara Previdi, Anastasia Malek, Veronica Albertini, et al.
Frontiers in Oncology
|
May 31, 2019
Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
Gianluca Civenni, Domenico Albino, Dheeraj Shinde, et al.
Neoplasia (New York, N.Y.)
|
October 13, 2006
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells
Sara Vignati, Veronica Albertini, Andrea Rinaldi, et al.
Nucleic Acids Research
|
May 4, 2004
DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene
Giuseppina M Carbone, Eileen McGuffie, Sara Napoli, et al.
Plos One
|
May 19, 2010
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer
Paolo Kunderfranco, Maurizia Mello-Grand, Romina Cangemi, et al.
Cancers
|
August 12, 2023
Potential of miRNAs in Plasma Extracellular Vesicle for the Stratification of Prostate Cancer in a South African Population
Dada Oluwaseyi Temilola, Martha Wium, Juliano Paccez, et al.
Cancers
|
December 10, 2021
Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma
Shusil K Pandit, Giada Sandrini, Jessica Merulla, et al.
Cancer Research
|
September 26, 2013
RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer
Gianluca Civenni, Anastasia Malek, Domenico Albino, et al.
Molecular Cancer Therapeutics
|
January 31, 2016
EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB
Gianluca Civenni, Nicole Longoni, Paula Costales, et al.
European Urology
|
July 2, 2011
Epigenetics in prostate cancer: biologic and clinical relevance
Carmen Jerónimo, Patrick J Bastian, Anders Bjartell, et al.
Page
of 5